Hemolytic anemia medical therapy: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) No edit summary |
Shyam Patel (talk | contribs) |
||
| Line 9: | Line 9: | ||
==Medical Therapy== | ==Medical Therapy== | ||
*'''[[Corticosteroids'' | *'''[[Corticosteroids]]''': The cornerstone of therapy for warm autoimmune hemolytic anemia is steroids. Steroids are the first-line therapy for induction of a response. The initial regimen of steroids is usually prednisone 1-1.5 mg/kg PO daily, to be continues for 1-3 weeks until the hemoglobin increases to 10 g/dl. | ||
==References== | ==References== | ||
Revision as of 16:34, 19 October 2017
|
Hemolytic anemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemolytic anemia medical therapy On the Web |
|
American Roentgen Ray Society Images of Hemolytic anemia medical therapy |
|
Risk calculators and risk factors for Hemolytic anemia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]
Overview
Treatment depends on the cause and nature of the breakdown.
Medical Therapy
- Corticosteroids: The cornerstone of therapy for warm autoimmune hemolytic anemia is steroids. Steroids are the first-line therapy for induction of a response. The initial regimen of steroids is usually prednisone 1-1.5 mg/kg PO daily, to be continues for 1-3 weeks until the hemoglobin increases to 10 g/dl.